WHAT IS THE CDDF?
The Cancer Drug Development Forum (CDDF) is a non-profit organisation registered in Belgium that provides a neutral platform to stimulate interaction between stakeholders involved in cancer drug development.
The CDDF’s mission is to facilitate collaboration between stakeholders, to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.
Its integrative approach brings together leading voices from academia, the pharmaceutical industry, regulatory authorities, policymakers and patient advocacy groups to improve cancer treatment.
HISTORY
Established in 2001 as the Biotherapy Development Association (BDA), the initial focus of the organisation was immunotherapy. In recognition of the importance of embracing all forms of oncology drug development, the association changed its name to the Cancer Drug Development Forum (CDDF) in 2014.
This new name clearly represents CDDF’s mission to facilitate an exchange of experience from all parties dedicated to developing cancer drugs and delivering effective treatment to patients. The CDDF plays a key role in
identifying silos and starting dialogue and collaboration, in particular by fully integrating the voice of patients.